Tamoxifen metabolism in breast cancer treatment: Taking the focus off the CYP2D6 gene

被引：4

作者：

Novillo, A. ^{[1
]}

Romero-Lorca, A. ^{[1
]}

Gaibar, M. ^{[1
]}

Rubio, M. ^{[1
]}

Fernandez-Santander, A. ^{[1
]}

机构：

[1] Univ Europea Madrid, Fac Biomed & Hlth Sci, Dept Basic Biomed Sci, Tajo S-N, Madrid 28670, Spain

来源：

PHARMACOGENOMICS JOURNAL | 2017年 / 17卷 / 02期

关键词：

ENDOXIFEN LEVEL; THERAPY; PHARMACOGENETICS; OUTCOMES; PHARMACOKINETICS; POLYMORPHISMS;

D O I：

10.1038/tpj.2016.73

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：109 / 111

页数：3

共 15 条

[1] Contribution of ABCB1 and CYP2D6 Genotypes to the Outcome of Tamoxifen Adjuvant Treatment in Premenopausal Women With Breast Cancer [J].

Argalacsova, S. ;

Slanar, O. ;

Vitek, P. ;

Tesarova, P. ;

Bakhouche, H. ;

Drazdakova, M. ;

Bartosova, O. ;

Zima, T. ;

Pertuzelka, L. .

PHYSIOLOGICAL RESEARCH, 2015, 64 :S539-S547

[2] Individualization of tamoxifen therapy: Much more than just CYP2D6 genotyping [J].

Binkhorst, Lisette ;

Mathijssen, Ron H. J. ;

Jager, Agnes ;

van Gelder, Teun .

CANCER TREATMENT REVIEWS, 2015, 41 (03) :289-299

[3] Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen [J].

Binkhorst, Lisette ;

Mathijssen, Ron H. J. ;

van Herk-Sukel, Myrthe P. P. ;

Bannink, Marjolein ;

Jager, Agnes ;

Wiemer, Erik A. C. ;

van Gelder, Teun .

BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (03) :923-929

[4] Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? [J].

Del Re, M. ;

Citi, V. ;

Crucitta, S. ;

Rofi, E. ;

Belcari, F. ;

van Schaik, R. H. ;

Danesi, R. .

PHARMACOLOGICAL RESEARCH, 2016, 107 :398-406

[5] Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen [J].

Dowsett, Mitch ;

Cuzick, Jack ;

Ingle, Jim ;

Coates, Alan ;

Forbes, John ;

Bliss, Judith ;

Buyse, Marc ;

Baum, Michael ;

Buzdar, Aman ;

Colleoni, Marco ;

Coombes, Charles ;

Snowdon, Claire ;

Gnant, Michael ;

Jakesz, Raimund ;

Kaufmann, Manfred ;

Boccardo, Francesco ;

Godwin, Jon ;

Davies, Christina ;

Peto, Richard .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) :509-518

[6] Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients [J].

Fernandez-Santander, Ana ;

Gaibar, Maria ;

Novillo, Apolonia ;

Romero-Lorca, Alicia ;

Rubio, Margarita ;

Chicharro, Luis Miguel ;

Tejerina, Armando ;

Bandres, Fernando .

PLOS ONE, 2013, 8 (07)

[7] Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study [J].

Fox, Peter ;

Balleine, Rosemary L. ;

Lee, Clara ;

Gao, Bo ;

Balakrishnar, Bavanthi ;

Menzies, Alexander M. ;

Yeap, Shang Heng ;

Ali, Sayed Sahanawaz ;

Gebski, Val ;

Provan, Pamela ;

Coulter, Sally ;

Liddle, Christopher ;

Hui, Rina ;

Kefford, Richard ;

Lynch, Jodi ;

Wong, Mark ;

Wilcken, Nicholas ;

Gurney, Howard .

CLINICAL CANCER RESEARCH, 2016, 22 (13) :3164-3171

[8] Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients [J].

Kiyotani, Kazuma ;

Mushiroda, Taisei ;

Imamura, Chiyo K. ;

Hosono, Naoya ;

Tsunoda, Tatsuhiko ;

Kubo, Michiaki ;

Tanigawara, Yusuke ;

Flockhart, David A. ;

Desta, Zeruesenay ;

Skaar, Todd C. ;

Aki, Fuminori ;

Hirata, Koichi ;

Takatsuka, Yuichi ;

Okazaki, Minoru ;

Ohsumi, Shozo ;

Yamakawa, Takashi ;

Sasa, Mitsunori ;

Nakamura, Yusuke ;

Zembutsu, Hitoshi .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) :1287-1293

[9] Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer [J].

Lim, Hyeong-Seok ;

Lee, Han Ju ;

Lee, Keun Seok ;

Lee, Eun Sook ;

Jang, In-Jin ;

Ro, Jungsil .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) :3837-3845

[10] Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes [J].

Madlensky, L. ;

Natarajan, L. ;

Tchu, S. ;

Pu, M. ;

Mortimer, J. ;

Flatt, S. W. ;

Nikoloff, D. M. ;

Hillman, G. ;

Fontecha, M. R. ;

Lawrence, H. J. ;

Parker, B. A. ;

Wu, A. H. B. ;

Pierce, J. P. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (05) :718-725

← 1 2 →